Predictive value of DNA methylation patterns in AML patients treated with an azacytidine containing induction regimen

BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous disease with a poor prognosis. Dysregulation of the epigenetic machinery is a significant contributor to disease development. Some AML patients benefit from treatment with hypomethylating agents (HMAs), but no predictive biomarkers for ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmutz, Maximilian, Zucknick, Manuela, Schlenk, Richard F., Mertens, Daniel, Benner, Axel, Weichenhan, Dieter, Mücke, Oliver, Döhner, Konstanze, Plass, Christoph, Bullinger, Lars, Claus, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601277/
https://www.ncbi.nlm.nih.gov/pubmed/37885041
http://dx.doi.org/10.1186/s13148-023-01580-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601277/
https://www.ncbi.nlm.nih.gov/pubmed/37885041
http://dx.doi.org/10.1186/s13148-023-01580-z

Ejemplares similares